As of April 1, 2026, Radiopharm Theranostics Limited American Depositary Shares (RADX) are trading at $4.32, posting a 0.47% gain in the most recent trading session. This analysis examines key technical levels, prevailing market context, and potential near-term scenarios for RADX, with a focus on factors driving current price action for the theranostics-focused equity. No recent earnings data is available for RADX at the time of writing, so recent price movement has been driven primarily by sect
RADX Stock Analysis: Radiopharm Theranostics biotech ADS at 4.32 with minor gain
RADX - Stock Analysis
3823 Comments
725 Likes
1
Weslyn
Trusted Reader
2 hours ago
{协议答案}
👍 258
Reply
2
Hilding
Active Contributor
5 hours ago
{协议答案}
👍 258
Reply
3
Niyara
Active Contributor
1 day ago
{协议答案}
👍 90
Reply
4
Rexanne
Power User
1 day ago
{协议答案}
👍 267
Reply
5
Dondi
Senior Contributor
2 days ago
{协议答案}
👍 266
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.